Logotype for Certara Inc

Certara (CERT) investor relations material

Certara Morgan Stanley 23rd Annual Global Healthcare Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Certara Inc
Morgan Stanley 23rd Annual Global Healthcare Conference summary10 Sep, 2025

Growth strategy and investments

  • Accelerated growth targeted through investments in sales, marketing, and R&D, with a focus on software platforms and AI-enabled solutions, especially Certara IQ for QSP launching in Q4.

  • New product rollouts include cloud-based Phoenix with AI enhancements and Pinnacle 21 for Enterprise, aiming to drive organic growth despite subdued market conditions.

  • Customer pain points addressed by enabling faster identification of drug trial failures, saving time and money in drug development.

  • Certara Cloud, launched in April 2024, has seen rapid adoption, especially among large biopharma, enhancing cross-product awareness and customer engagement.

  • Tier three (biotech) customer performance exceeded expectations due to targeted commercial efforts, while tier one (large biopharma) bookings impacted by timing but expected to recover.

Product innovation and AI integration

  • Certara IQ, an AI-enabled QSP software, is a key focus, leveraging expertise from the Vyasa acquisition and new CTO leadership.

  • AI technology is being integrated internally to improve workflow efficiency and externally through products like co-author, which reduces regulatory writing time by 40%.

  • Customers seek technology that enables earlier identification of molecule failures and process inefficiencies, with Certara positioned to support efficiency across the drug development cycle.

Market environment and regulatory landscape

  • Policy changes and funding challenges persist, especially for biotech clients, but FDA directives to reduce animal testing create tailwinds for biosimulation products like SIMCYP and QSP.

  • Certara’s longstanding relationship with the FDA, whose staff are major users of its software, provides a competitive advantage and smooths regulatory submissions for clients.

  • 90% of FDA drug approvals in 2014 involved Certara’s products or services, highlighting broad market penetration and future growth potential through deeper customer engagement.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Certara earnings date

Logotype for Certara Inc
Q3 20256 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Certara earnings date

Logotype for Certara Inc
Q3 20256 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Certara Inc. is a life sciences technology company that provides software and services to accelerate drug development and regulatory approval processes. The company specializes in biosimulation, a technology that uses virtual models to predict how drugs behave in the human body, helping pharmaceutical companies optimize clinical trials and drug development strategies. Certara’s offerings support decision-making throughout the drug development lifecycle, from discovery through post-market stages, across a range of therapeutic areas. The company is headquartered in Princeton, New Jersey, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage